Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Frank

Showing results (781-790 of 796) with videos related to

Pageof 80
Sort By:
Bioorganic & Medicinal Chemistry Letters|September 16, 2015
Structure activity optimization of 6H-pyrrolo[2,3-e][1,2,4]triazolo[4,3-a]pyrazines as Jak1 kinase inhibitorsMichael Friedman, Kristine E Frank, Ana Aguirre, et al.
Medicine|July 3, 2019
Long-term treatment with eteplirsen in nonambulatory patients with Duchenne muscular dystrophyLindsay N Alfano, Jay S Charleston, Anne M Connolly, et al.
Leukemia|June 13, 2008
On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemiaE J Feldman, J Cortes, D J DeAngelo, et al.
Science Advances|October 16, 2024
2'3'-cGAMP interactome identifies 2'3'-cGAMP/Rab18/FosB signaling in cell migration control independent of innate immunityYu Deng, Quentin Hahn, Le Yu, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2009
2,4-Diaminopyrimidine MK2 inhibitors. Part II: Structure-based inhibitor optimizationChristopher M Harris, Anna M Ericsson, Maria A Argiriadi, et al.
Molecular Psychiatry|October 12, 2016
Structural brain changes are associated with response of negative symptoms to prefrontal repetitive transcranial magnetic stimulation in patients with schizophreniaA Hasan, T Wobrock, B Guse, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 24, 2025
Small molecule interleukin (IL) 17A/A antagonists and antibodies blocking both IL17A/A and IL17A/F demonstrate equivalent degrees of efficacy in preclinical models of skin and joint inflammationEric R Goedken, Zhi Su, Alex Lipovsky, et al.
Molecular Psychiatry|April 7, 2010
TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studiesA Erhardt, L Czibere, D Roeske, et al.
JAMA Neurology|May 30, 2023
Symptomatic Intracranial Hemorrhage With Tenecteplase vs Alteplase in Patients With Acute Ischemic Stroke: The Comparative Effectiveness of Routine Tenecteplase vs Alteplase in Acute Ischemic Stroke (CERTAIN) CollaborationSteven J Warach, Anna Ranta, Joosup Kim, et al.
Journal of Medicinal Chemistry|April 4, 2024
Discovery of Small Molecule Interleukin 17A Inhibitors with Novel Binding Mode and Stoichiometry: Optimization of DNA-Encoded Chemical Library Hits to In Vivo Active CompoundsAshley L Ramos, Eric R Goedken, Kristine E Frank, et al.
Pageof 80

Showing results (781-790 of 796) with videos related to

Sort By:
Pageof 80
Bioorganic & Medicinal Chemistry Letters|September 16, 2015
Structure activity optimization of 6H-pyrrolo[2,3-e][1,2,4]triazolo[4,3-a]pyrazines as Jak1 kinase inhibitorsMichael Friedman, Kristine E Frank, Ana Aguirre, et al.
Medicine|July 3, 2019
Long-term treatment with eteplirsen in nonambulatory patients with Duchenne muscular dystrophyLindsay N Alfano, Jay S Charleston, Anne M Connolly, et al.
Leukemia|June 13, 2008
On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemiaE J Feldman, J Cortes, D J DeAngelo, et al.
Science Advances|October 16, 2024
2'3'-cGAMP interactome identifies 2'3'-cGAMP/Rab18/FosB signaling in cell migration control independent of innate immunityYu Deng, Quentin Hahn, Le Yu, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2009
2,4-Diaminopyrimidine MK2 inhibitors. Part II: Structure-based inhibitor optimizationChristopher M Harris, Anna M Ericsson, Maria A Argiriadi, et al.
Molecular Psychiatry|October 12, 2016
Structural brain changes are associated with response of negative symptoms to prefrontal repetitive transcranial magnetic stimulation in patients with schizophreniaA Hasan, T Wobrock, B Guse, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 24, 2025
Small molecule interleukin (IL) 17A/A antagonists and antibodies blocking both IL17A/A and IL17A/F demonstrate equivalent degrees of efficacy in preclinical models of skin and joint inflammationEric R Goedken, Zhi Su, Alex Lipovsky, et al.
Molecular Psychiatry|April 7, 2010
TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studiesA Erhardt, L Czibere, D Roeske, et al.
JAMA Neurology|May 30, 2023
Symptomatic Intracranial Hemorrhage With Tenecteplase vs Alteplase in Patients With Acute Ischemic Stroke: The Comparative Effectiveness of Routine Tenecteplase vs Alteplase in Acute Ischemic Stroke (CERTAIN) CollaborationSteven J Warach, Anna Ranta, Joosup Kim, et al.
Journal of Medicinal Chemistry|April 4, 2024
Discovery of Small Molecule Interleukin 17A Inhibitors with Novel Binding Mode and Stoichiometry: Optimization of DNA-Encoded Chemical Library Hits to In Vivo Active CompoundsAshley L Ramos, Eric R Goedken, Kristine E Frank, et al.
Pageof 80